The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
Open accessAbstract
Type 2 diabetes mellitus is characterized by the dysregulation of glucose homeostasis, resulting in hyperglycaemia. Although current diabetes treatments have exhibited some success in lowering blood glucose levels, their effect is not always sustained and their use may be associated with undesirable side effects, such as hypoglycaemia. Novel antidiabetic drugs, which may be used in combination with existing therapies, are therefore needed. The potential of specifically targeting the liver to normalize blood glucose levels has not been fully exploited. Here, we review the molecular mechanisms controlling hepatic gluconeogenesis and glycogen storage, and assess the prospect of therapeutically targeting associated pathways to treat type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
Self-citationDrucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Self-citationNutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Self-citationInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Mihaylova, M. M., & Shaw, R. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2329 · Cited by 2,923
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133
Gonzalez, G. A., & Montminy, M. R. (1989) · Cell · doi:10.1016/0092-8674(89)90013-5 · Cited by 2,464
Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.-C., et al. (1999) · Science · doi:10.1126/science.283.5407.1544 · Cited by 2,210
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
Phosphorylated CREB binds specifically to the nuclear protein CBP
Chrivia, J. C., Kwok, R. P. S., Lamb, N., Hagiwara, M., Montminy, M. R., & Goodman, R. H. (1993) · Nature · doi:10.1038/365855a0 · Cited by 2,052
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Self-citationPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Metformin: from mechanisms of action to therapies
Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Self-citationThe pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationEl-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284
PGC-1α: a key regulator of energy metabolism
Liang, H., & Ward, W. F. (2006) · Advances in Physiology Education · doi:10.1152/advan.00052.2006 · Cited by 1,245
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181
Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162
Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139
SIRT1 and other sirtuins in metabolism
Chang, H.-C., & Guarente, L. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.12.001 · Cited by 1,133
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
Koo, S.-H., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., et al. (2005) · Nature · doi:10.1038/nature03967 · Cited by 995
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Embi, N., Rylatt, D. B., & Cohen, P. (1980) · PubMed · Cited by 911
Coghlan, M. P., Culbert, A. A., Cross, D. A., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O. L., Murphy, G. J., Carter, P. S., Roxbee Cox, L., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00025-9 · Cited by 897
Fullerton, M. D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H. M., Ford, R. J., Palanivel, R., O'Brien, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3372 · Cited by 893
AMPK, insulin resistance, and the metabolic syndrome
Ruderman, N. B., Carling, D., Prentki, M., & Cacicedo, J. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67227 · Cited by 873
A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila , and Humans
Bricker, D. K., Taylor, E. B., Schell, J. C., Orsak, T., Boutron, A., Chen, Y.-C., Cox, J. E., Cardon, C. M., Van Vranken, J. G., Dephoure, N., et al. (2012) · Science · doi:10.1126/science.1218099 · Cited by 843
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Miller, R. A., Chu, Q., Xie, J., Foretz, M., Viollet, B., & Birnbaum, M. J. (2013) · Nature · doi:10.1038/nature11808 · Cited by 833
Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists
Solt, L. A., Wang, Y., Banerjee, S., Hughes, T., Kojetin, D. J., Lundasen, T., Shin, Y., Liu, J., Cameron, M. D., Noel, R., et al. (2012) · Nature · doi:10.1038/nature11030 · Cited by 831
SGLT2 inhibition — a novel strategy for diabetes treatment
Chao, E. C., & Henry, R. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3180 · Cited by 822
GSK3 inhibitors: development and therapeutic potential
Cohen, P., & Goedert, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1415 · Cited by 790
Magnusson, I., Rothman, D. L., Katz, L. D., Shulman, R. G., & Shulman, G. I. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115997 · Cited by 757
Identification and Functional Expression of the Mitochondrial Pyruvate Carrier
Herzig, S., Raemy, E., Montessuit, S., Veuthey, J.-L., Zamboni, N., Westermann, B., Kunji, E. R. S., & Martinou, J.-C. (2012) · Science · doi:10.1126/science.1218530 · Cited by 747
Abdul-Ghani, M. A., Tripathy, D., & DeFronzo, R. A. (2006) · Diabetes Care · doi:10.2337/dc05-2179 · Cited by 744
Perry, R. J., Camporez, J.-P. G., Kursawe, R., Titchenell, P. M., Zhang, D., Perry, C. J., Jurczak, M. J., Abudukadier, A., Han, M. S., Zhang, X.-M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.012 · Cited by 719
Rev-erbα, a Heme Sensor That Coordinates Metabolic and Circadian Pathways
Yin, L., Wu, N., Curtin, J. C., Qatanani, M., Szwergold, N. R., Reid, R. A., Waitt, G. M., Parks, D. J., Pearce, K. H., Wisely, G. B., et al. (2007) · Science · doi:10.1126/science.1150179 · Cited by 707
Cline, G. W., Petersen, K. F., Krssak, M., Shen, J., Hundal, R. S., Trajanoski, Z., Inzucchi, S., Dresner, A., Rothman, D. L., & Shulman, G. I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410404 · Cited by 675
Transcriptional coactivator PGC-1α integrates the mammalian clock and energy metabolism
Liu, C., Li, S., Liu, T., Borjigin, J., & Lin, J. D. (2007) · Nature · doi:10.1038/nature05767 · Cited by 643
Metformin in Patients With Type 2 Diabetes and Kidney Disease: A Systematic Review
Inzucchi, S. E., Lipska, K. J., Mayo, H., Bailey, C. J., & McGuire, D. K. (2014) · JAMA · doi:10.1001/jama.2014.15298 · Cited by 601
REV-ERB and ROR nuclear receptors as drug targets
Kojetin, D. J., & Burris, T. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4100 · Cited by 576
Metformin: An Old But Still the Best Treatment for Type 2 Diabetes
Rojas, L. B. A., & Gomes, M. B. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-6 · Cited by 567
Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis
Zhang, E. E., Liu, Y., Dentin, R., Pongsawakul, P. Y., Liu, A. C., Hirota, T., Nusinow, D. A., Sun, X., Landais, S., Kodama, Y., et al. (2010) · Nature Medicine · doi:10.1038/nm.2214 · Cited by 567
Rhee, J., Inoue, Y., Yoon, J. C., Puigserver, P., Fan, M., Gonzalez, F. J., & Spiegelman, B. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730870100 · Cited by 567
Self-citationThe Biology of Mitochondrial Uncoupling Proteins
Rousset, S., Alves-Guerra, M.-C., Mozo, J., Miroux, B., Cassard-Doulcier, A.-M., Bouillaud, F., & Ricquier, D. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s130 · Cited by 553
PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M. (2004) · Nature Medicine · doi:10.1038/nm1044 · Cited by 550
Quantitation of Hepatic Glycogenolysis And Gluconeogenesis in Fasting Humans With 13 C NMR
Rothman, D. L., Magnusson, I., Katz, L. D., Shulman, R. G., & Shulman, G. I. (1991) · Science · doi:10.1126/science.1948033 · Cited by 546
Mihaylova, M. M., Vasquez, D. S., Ravnskjaer, K., Denechaud, P.-D., Yu, R. T., Alvarez, J. G., Downes, M., Evans, R. M., Montminy, M., & Shaw, R. J. (2011) · Cell · doi:10.1016/j.cell.2011.03.043 · Cited by 533
Ring, D. B., Johnson, K. W., Henriksen, E. J., Nuss, J. M., Goff, D., Kinnick, T. R., Ma, S. T., Reeder, J. W., Samuels, I., Slabiak, T., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.3.588 · Cited by 532
Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes
Soccio, R. E., Chen, E. R., & Lazar, M. A. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.005 · Cited by 518
Novel concepts in insulin regulation of hepatic gluconeogenesis
Barthel, A., & Schmoll, D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00253.2003 · Cited by 515
Identification of Small Molecule Activators of Cryptochrome
Hirota, T., Lee, J. W., St. John, P. C., Sawa, M., Iwaisako, K., Noguchi, T., Pongsawakul, P. Y., Sonntag, T., Welsh, D. K., Brenner, D. A., et al. (2012) · Science · doi:10.1126/science.1223710 · Cited by 499
The glucose-6-phosphatase system
SCHAFTINGEN, E. V., & Gerin, I. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3620513 · Cited by 495
Thiebaud, D., Jacot, E., Defronzo, R. A., Maeder, E., Jequier, E., & Felber, J.-P. (1982) · Diabetes · doi:10.2337/diacare.31.11.957 · Cited by 489
Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family
Xu, J., Wu, R.-C., & O'Malley, B. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2695 · Cited by 488
Contributions of gluconeogenesis to glucose production in the fasted state
Landau, B. R., Wahren, J., Chandramouli, V, Schumann, W. C., Ekberg, K., & Kalhan, S. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118803 · Cited by 487
Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator
Li, X., Monks, B., Ge, Q., & Birnbaum, M. J. (2007) · Nature · doi:10.1038/nature05861 · Cited by 487
2,4-Dinitrophenol (DNP): A Weight Loss Agent with Significant Acute Toxicity and Risk of Death
Grundlingh, J., Dargan, P. I., El-Zanfaly, M., & Wood, D. M. (2011) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0162-6 · Cited by 470
Role of the liver in the control of carbohydrate and lipid homeostasis
Postic, C., Dentin, R., & Girard, J. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70133-7 · Cited by 448
The Control of Glycogen Metabolism in the Liver
Hers, H. G. (1976) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.45.070176.001123 · Cited by 448
Lerin, C., Rodgers, J. T., Kalume, D. E., Kim, S.-H., Pandey, A., & Puigserver, P. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.013 · Cited by 443
Self-citationHormonal regulation of hepatic glucose production in health and disease
Lin, H. V., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.003 · Cited by 429
How does SIRT1 affect metabolism, senescence and cancer?
Brooks, C. L., & Gu, W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2562 · Cited by 428
The control of glycogen metabolism in the liver
Hers, H. G., De Wulf, H., & Stalmans, W. (1970) · FEBS Letters · doi:10.1016/0014-5793(70)80569-5 · Cited by 414
Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM
Consoli, A., Nurjhan, N., Capani, F., & Gerich, J. (1989) · Diabetes · doi:10.2337/diab.38.5.550 · Cited by 406
Assessing the potential of glucokinase activators in diabetes therapy
Matschinsky, F. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2850 · Cited by 401
Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2
Dentin, R., Liu, Y., Koo, S.-H., Hedrick, S., Vargas, T., Heredia, J., Yates, J., & Montminy, M. (2007) · Nature · doi:10.1038/nature06128 · Cited by 400
Targeting the disordered C terminus of PTP1B with an allosteric inhibitor
Krishnan, N., Koveal, D., Miller, D. H., Xue, B., Akshinthala, S. D., Kragelj, J., Jensen, M. R., Gauss, C.-M., Page, R., Blackledge, M., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1528 · Cited by 372
Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.
Rizza, R. A. (2010) · Diabetes · doi:10.2337/db10-1032 · Cited by 367
Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin
Granner, D., Andreone, T., Sasaki, K., & Beale, E. (1983) · Nature · doi:10.1038/305549a0 · Cited by 362
Wulffelé, M. G., Kooy, A., de Zeeuw, D., Stehouwer, C. D. A., & Gansevoort, R. T. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01328.x · Cited by 359
Nikoulina, S. E., Ciaraldi, T. P., Mudaliar, S., Mohideen, P., Carter, L., & Henry, R. R. (2000) · Diabetes · doi:10.2337/diabetes.49.2.263 · Cited by 357
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
Eldar-Finkelman, H., & Martinez, A. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00032 · Cited by 354
Regulation of Hepatic Glucose Uptake and Storage In Vivo
Moore, M. C., Coate, K. C., Winnick, J. J., An, Z., & Cherrington, A. D. (2012) · Advances in Nutrition · doi:10.3945/an.112.002089 · Cited by 354
Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
Calcutt, N. A., Cooper, M. E., Kern, T. S., & Schmidt, A. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2476 · Cited by 352
Hutson, N. J., Brumley, F. T., Assimacopoulos, F. D., Harper, S. C., & Exton, J. H. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33147-2 · Cited by 348
CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ
Herzig, S., Hedrick, S., Morantte, I., Koo, S.-H., Galimi, F., & Montminy, M. (2003) · Nature · doi:10.1038/nature02110 · Cited by 321
A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy
Tolosa, E., Litvan, I., Höglinger, G. U., Burn, D., Lees, A., Andrés, M. V., Gómez‐Carrillo, B., León, T., del Ser, T., & for the TAUROS Investigators (2014) · Movement Disorders · doi:10.1002/mds.25824 · Cited by 320
Newgard, C. B., Hirsch, L. J., Foster, D. W., & McGarry, J. D. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82025-0 · Cited by 314
Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes.
Krssak, M., Brehm, A., Bernroider, E., Anderwald, C., Nowotny, P., Man, C. D., Cobelli, C., Cline, G. W., Shulman, G. I., Waldhäusl, W., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3048 · Cited by 313
The Antihyperglycaemic Effect of Metformin: Therapeutic and Cellular Mechanisms
Wiernsperger, N. F., & Bailey, C. J. (1999) · Drugs · doi:10.2165/00003495-199958001-00009 · Cited by 312
Insulin resistance and the metabolic syndrome
Landsberg, L. (2005) · Diabetologia · doi:10.1007/s00125-005-1818-z · Cited by 309
Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier
Divakaruni, A. S., Wiley, S. E., Rogers, G. W., Andreyev, A. Y., Petrosyan, S., Loviscach, M., Wall, E. A., Yadava, N., Heuck, A. P., Ferrick, D. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303360110 · Cited by 308
Baron, A. D., Schaeffer, L., Shragg, P., & Kolterman, O. G. (1987) · Diabetes · doi:10.2337/diab.36.3.274 · Cited by 308
Deconstructing Type 2 Diabetes
Taylor, S. I. (1999) · Cell · doi:10.1016/s0092-8674(00)80709-6 · Cited by 307
Valera, A., Pujol, A., Pelegrin, M., & Bosch, F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9151 · Cited by 301
The Deacetylase Sirt6 Activates the Acetyltransferase GCN5 and Suppresses Hepatic Gluconeogenesis
Dominy, J. E., Lee, Y., Jedrychowski, M. P., Chim, H., Jurczak, M. J., Camporez, J. P., Ruan, H.-B., Feldman, J., Pierce, K., Mostoslavsky, R., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.030 · Cited by 294
Self-citationSulphonylurea action revisited: the post-cloning era
Gribble, F. M., & Reimann, F. (2003) · Diabetologia · doi:10.1007/s00125-003-1143-3 · Cited by 284
Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
Perry, R. J., Zhang, D., Zhang, X.-M., Boyer, J. L., & Shulman, G. I. (2015) · Science · doi:10.1126/science.aaa0672 · Cited by 283
Delibegovic, M., Zimmer, D., Kauffman, C., Rak, K., Hong, E.-G., Cho, Y.-R., Kim, J. K., Kahn, B. B., Neel, B. G., & Bence, K. K. (2009) · Diabetes · doi:10.2337/db08-0913 · Cited by 280
Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier
Vacanti, N. M., Divakaruni, A. S., Green, C. R., Parker, S. J., Henry, R. R., Ciaraldi, T. P., Murphy, A. N., & Metallo, C. M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.024 · Cited by 277
Targeting Transcription Factors in Cancer
Bhagwat, A. S., & Vakoc, C. R. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.07.001 · Cited by 276
Burgess, S. C., He, T., Yan, Z., Lindner, J., Sherry, A. D., Malloy, C. R., Browning, J. D., & Magnuson, M. A. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.004 · Cited by 276
Nagashima, T., Shigematsu, N., Maruki, R., Urano, Y., Tanaka, H., Shimaya, A., Shimokawa, T., & Shibasaki, M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065714 · Cited by 275
Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis
Meyer, C., Dostou, J. M., Welle, S. L., & Gerich, J. E. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00032.2001 · Cited by 269
Mitochondrial pyruvate transport: a historical perspective and future research directions
McCommis, K. S., & Finck, B. N. (2015) · Biochemical Journal · doi:10.1042/bj20141171 · Cited by 269
Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis.
Radziuk, J., & Pye, S. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.217 · Cited by 267
Farfari, S., Schulz, V, Corkey, B., & Prentki, M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.718 · Cited by 266
Activation of nuclear receptor coactivator PGC-1α by arginine methylation
Teyssier, C., Ma, H., Emter, R., Kralli, A., & Stallcup, M. R. (2005) · Genes & Development · doi:10.1101/gad.1295005 · Cited by 260
Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus
Treadway, J. L., Mendys, P., & Hoover, D. J. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.3.439 · Cited by 260
Phosphoenolpyruvate Carboxykinase Is Necessary for the Integration of Hepatic Energy Metabolism
She, P., Shiota, M., Shelton, K. D., Chalkley, R. G., Postic, C., & Magnuson, M. A. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.17.6508-6517.2000 · Cited by 257
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
Hammitzsch, A., Tallant, C., Fedorov, O., O’Mahony, A., Brennan, P. E., Hay, D. A., Martinez, F. O., Al-Mossawi, M. H., de Wit, J., Vecellio, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501956112 · Cited by 254
Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.
Eldar-Finkelman, H., Schreyer, S. A., Shinohara, M. M., LeBoeuf, R. C., & Krebs, E. G. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1662 · Cited by 252
Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
Domínguez, J. M., Fuertes, A., Orozco, L., del Monte-Millán, M., Delgado, E., & Medina, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.306472 · Cited by 246
The role of dysregulated glucagon secretion in type 2 diabetes
D'Alessio, D. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01449.x · Cited by 238
Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression
Lee, Y., Dominy, J. E., Choi, Y. J., Jurczak, M., Tolliday, N., Camporez, J. P., Chim, H., Lim, J.-H., Ruan, H.-B., Yang, X., et al. (2014) · Nature · doi:10.1038/nature13267 · Cited by 234
Self-citationDiscovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo
Martin, W. H., Hoover, D. J., Armento, S. J., Stock, I. A., McPherson, R. K., Danley, D. E., Stevenson, R. W., Barrett, E. J., & Treadway, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1776 · Cited by 232
Lantz, K. A., Hart, S. G. E., Planey, S. L., Roitman, M. F., Ruiz‐White, I. A., Wolfe, H. R., & McLane, M. P. (2010) · Obesity · doi:10.1038/oby.2009.444 · Cited by 232
Perry, R. J., Kim, T., Zhang, X.-M., Lee, H.-Y., Pesta, D., Popov, V. B., Zhang, D., Rahimi, Y., Jurczak, M. J., Cline, G. W., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.004 · Cited by 230
Insulinotropic meglitinide analogues
Dornhorst, A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06715-0 · Cited by 229
Antagonists of protein–protein interactions
Cochran, A. G. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00106-x · Cited by 228
Cline, G. W., Johnson, K., Regittnig, W., Perret, P., Tozzo, E., Xiao, L., Damico, C., & Shulman, G. I. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2903 · Cited by 228
Glucose–6–phosphatase dependent substrate transport in the glycogen storage disease type–1a mouse
Lei, K.-J., Chen, H., Pan, C.-J., Ward, J. M., Mosinger, B., Lee, E. J., Westphal, H., Mansfield, B. C., & Chou, J. Y. (1996) · Nature Genetics · doi:10.1038/ng0696-203 · Cited by 227
Gray, L. R., Sultana, M. R., Rauckhorst, A. J., Oonthonpan, L., Tompkins, S. C., Sharma, A., Fu, X., Miao, R., Pewa, A. D., Brown, K. S., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.027 · Cited by 224
Lochhead, P. A., Coghlan, M., Rice, S. Q. J., & Sutherland, C. (2001) · Diabetes · doi:10.2337/diabetes.50.5.937 · Cited by 219
McCommis, K. S., Chen, Z., Fu, X., McDonald, W. G., Colca, J. R., Kletzien, R. F., Burgess, S. C., & Finck, B. N. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.028 · Cited by 213
Kazda, C. M., Ding, Y., Kelly, R. P., Garhyan, P., Shi, C., Lim, C. N., Fu, H., Watson, D. E., Lewin, A. J., Landschulz, W. H., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1643 · Cited by 212
Petersen, K. F., & Sullivan, J. T. (2001) · Diabetologia · doi:10.1007/s001250100006 · Cited by 209
Identification of small-molecule antagonists that inhibit an activator:coactivator interaction
Best, J. L., Amezcua, C. A., Mayr, B., Flechner, L., Murawsky, C. M., Emerson, B., Zor, T., Gardner, K. H., & Montminy, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406374101 · Cited by 207
Metformin and digestive disorders
Bouchoucha, M., Uzzan, B., & Cohen, R. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.11.002 · Cited by 201
Esterbauer, H., Oberkofler, H., Krempler, F., & Patsch, W. (1999) · Genomics · doi:10.1006/geno.1999.5977 · Cited by 201
Cimbala, M. A., Lamers, W. H., Nelson, K., Monahan, J. E., Yoo-Warren, H., & Hanson, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34426-0 · Cited by 198
Insulin's direct effects on the liver dominate the control of hepatic glucose production
Edgerton, D. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27073 · Cited by 196
A brief introduction to FOXOlogy
Burgering, B. M. T. (2008) · Oncogene · doi:10.1038/onc.2008.29 · Cited by 194
Dominy, J. E., Lee, Y., Gerhart-Hines, Z., & Puigserver, P. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.023 · Cited by 192
Self-citationForkhead box class O transcription factors in liver function and disease
Tikhanovich, I., Cox, J., & Weinman, S. A. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12021 · Cited by 189
FoxOs Function Synergistically to Promote Glucose Production
Haeusler, R. A., Kaestner, K. H., & Accili, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.175851 · Cited by 186
3-Mercaptopicolinic acid, an inhibitor of gluconeogenesis
DiTullio, N. W., Berkoff, C. E., Blank, B., Kostos, V., Stack, E. J., & Saunders, H. L. (1974) · Biochemical Journal · doi:10.1042/bj1380387 · Cited by 181
Hepatic Suppression of Foxo1 and Foxo3 Causes Hypoglycemia and Hyperlipidemia in Mice
Zhang, K., Li, L., Qi, Y., Zhu, X., Gan, B., DePinho, R. A., Averitt, T., & Guo, S. (2012) · Endocrinology · doi:10.1210/en.2011-1527 · Cited by 179
Burgess, S. C., Hausler, N., Merritt, M., Jeffrey, F. M. H., Storey, C., Milde, A., Koshy, S., Lindner, J., Magnuson, M. A., Malloy, C. R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407120200 · Cited by 179
Fructose‐2,6‐bisphosphate and control of carbohydrate metabolism in eukaryotes
Okar, D. A., & Lange, A. J. (1999) · BioFactors · doi:10.1002/biof.5520100101 · Cited by 178
Suh, S. W., Bergher, J. P., Anderson, C. M., Treadway, J. L., Fosgerau, K., & Swanson, R. A. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.115550 · Cited by 178
Hwang, J. H., Perseghin, G., Rothman, D. L., Cline, G. W., Magnusson, I., Petersen, K. F., & Shulman, G. I. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117727 · Cited by 177
The REV-ERBs and RORs: Molecular Links Between Circadian Rhythms and Lipid Homeostasis
Solt, L. A., Kojetin, D. J., & Burris, T. P. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.9 · Cited by 176
Mutel, E., Gautier-Stein, A., Abdul-Wahed, A., Amigó-Correig, M., Zitoun, C., Stefanutti, A., Houberdon, I., Tourette, J.-A., Mithieux, G., & Rajas, F. (2011) · Diabetes · doi:10.2337/db11-0571 · Cited by 176
Samuel, V. T., Beddow, S. A., Iwasaki, T., Zhang, X.-M., Chu, X., Still, C. D., Gerhard, G. S., & Shulman, G. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812547106 · Cited by 176
Colca, J. R., McDonald, W. G., Cavey, G. S., Cole, S. L., Holewa, D. D., Brightwell-Conrad, A. S., Wolfe, C. L., Wheeler, J. S., Coulter, K. R., Kilkuskie, P. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061551 · Cited by 171
Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity
Wang, Y., Inoue, H., Ravnskjaer, K., Viste, K., Miller, N., Liu, Y., Hedrick, S., Vera, L., & Montminy, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914897107 · Cited by 167
Glycogen Phosphorylase as a Molecular Target for Type 2 Diabetes Therapy
Oikonomakos, N. (2002) · Current Protein & Peptide Science · doi:10.2174/1389203023380422 · Cited by 165
Lee, J.-M., Seo, W.-Y., Song, K.-H., Chanda, D., Kim, Y. D., Kim, D.-K., Lee, M.-W., Ryu, D., Kim, Y.-H., Noh, J.-R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134890 · Cited by 162
Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease
Chopra, A. R., Louet, J.-F., Saha, P., An, J., DeMayo, F., Xu, J., York, B., Karpen, S., Finegold, M., Moore, D., et al. (2008) · Science · doi:10.1126/science.1164847 · Cited by 161
Protein Tyrosine Phosphatase 1B (PTP1B) and Obesity
Cho, H. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00017-1 · Cited by 159
Rondinone, C. M., Trevillyan, J. M., Clampit, J., Gum, R. J., Berg, C., Kroeger, P., Frost, L., Zinker, B. A., Reilly, R., Ulrich, R., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2405 · Cited by 159
Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance
Kumashiro, N., Beddow, S. A., Vatner, D. F., Majumdar, S. K., Cantley, J. L., Guebre‐Egziabher, F., Fat, I., Guigni, B. A., Jurczak, M. J., Birkenfeld, A. L., et al. (2013) · Diabetes · doi:10.2337/db12-1311 · Cited by 158
New hepatic targets for glycaemic control in diabetes
Agius, L. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.09.001 · Cited by 155
The place of sulfonylureas in the therapy for type 2 diabetes mellitus
Prato, S. D., & Pulizzi, N. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.003 · Cited by 154
GSK4112, a Small Molecule Chemical Probe for the Cell Biology of the Nuclear Heme Receptor Rev-erbα
Grant, D., Yin, L., Collins, J. L., Parks, D. J., Orband‐Miller, L. A., Wisely, G. B., Joshi, S., Lazar, M. A., Willson, T. M., & Zuercher, W. J. (2010) · ACS Chemical Biology · doi:10.1021/cb100141y · Cited by 154
Estall, J. L., Kahn, M., Cooper, M. P., Fisher, F. M., Wu, M. K., Laznik, D., Qu, L., Cohen, D. E., Shulman, G. I., & Spiegelman, B. M. (2009) · Diabetes · doi:10.2337/db08-1571 · Cited by 150
Gallagher, E. J., & LeRoith, D. (2013) · Diabetes Care · doi:10.2337/dcs13-2001 · Cited by 149
New Inhibitors of Glycogen Phosphorylase as Potential Antidiabetic Agents
Somsák, L., Czifrák, K., Tóth, M., Bokor, É., Chrysina, E. D., Alexacou, K.-M., Hayes, J. M., Tiraidis, C., Lazoura, E., Leonidas, D. D., et al. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786848659 · Cited by 144
Magnuson, M. A., Quinn, P. G., & Granner, D. K. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48115-x · Cited by 143
FoxO6 Integrates Insulin Signaling With Gluconeogenesis in the Liver
Kim, D. H., Perdomo, G., Zhang, T., Slusher, S., Lee, S., Phillips, B. E., Fan, Y., Giannoukakis, N., Gramignoli, R., Strom, S. C., et al. (2011) · Diabetes · doi:10.2337/db11-0548 · Cited by 143
Tao, R., Wei, D., Gao, H., Liu, Y., DePinho, R. A., & Dong, X. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.201061 · Cited by 138
Dekker, F. J., van den Bosch, T., & Martin, N. I. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.012 · Cited by 137
Regulation of enzymes involved in gluconeogenesis
Weber, G., Singhal, R. L., Stamm, N. B., Fisher, E. A., & Mentendiek, M. A. (1964) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(64)80003-0 · Cited by 136
Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic Gluconeogenesis
Rodgers, J. T., Haas, W., Gygi, S. P., & Puigserver, P. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.006 · Cited by 134
Self-citationWajngot, A., Chandramouli, V., Schumann, W. C., Ekberg, K., Jones, P. K., Efendic, S., & Landau, B. R. (2001) · Metabolism · doi:10.1053/meta.2001.19422 · Cited by 130
Sources of carbon for hepatic glycogen synthesis in the conscious dog.
Moore, M. C., Cherrington, A. D., Cline, G. W., Pagliassotti, M. J., Jones, E. M., Neal, D. W., Badet, C., & Shulman, G. I. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115342 · Cited by 127
Novel Small-Molecule PGC-1α Transcriptional Regulator With Beneficial Effects on Diabetic db/db Mice
Zhang, L., Zhou, H., Fu, Y., Li, Y., Wu, F., Gu, M., Wu, L., Xia, C.-M., Dong, T., Li, J.-Y., et al. (2012) · Diabetes · doi:10.2337/db12-0703 · Cited by 127
Human liver glycogen phosphorylase inhibitors bind at a new allosteric site
Rath, V. L., Ammirati, M. J., Danley, D. E., Ekstrom, J. L., Gibbs, E. M., Hynes, T. R., Mathiowetz, A. M., McPherson, R. K., Olson, T. V., Treadway, J. L., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00004-1 · Cited by 126
Georgievska, B., Sandin, J., Doherty, J., Mörtberg, A., Neelissen, J. A. M., Andersson, A., Gruber, S. H. M., Nilsson, Y., Schött, P. A., Arvidsson, P. I., et al. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12203 · Cited by 125
Wrobel, J. E., Sredy, J., Moxham, C., Dietrich, A., Li, Z., Sawicki, D. R., Seestaller, L. M., Wu, L., Katz, A. H., Sullivan, D. S., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990260v · Cited by 125
Identification of SR3335 (ML-176): A Synthetic RORα Selective Inverse Agonist
Kumar, N., Kojetin, D. J., Solt, L. A., et al. (2010) · ACS Chemical Biology · doi:10.1021/cb1002762 · Cited by 125
Small Molecule Inhibition of the Steroid Receptor Coactivators, SRC-3 and SRC-1
Wang, Y., Lonard, D. M., Yu, Y., Chow, D., Palzkill, T. G., & O’Malley, B. W. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1222 · Cited by 122
Hakimi, P., Johnson, M. T., Yang, J., LePage, D. F., Conlon, R. A., Kalhan, S. C., Reshef, L., Tilghman, S. M., & Hanson, R. W. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-33 · Cited by 121
Separation of the gluconeogenic and mitochondrial functions of PGC-1α through S6 kinasePreprint
Lustig, Y., Ruas, J. L., Estall, J. L., Lo, J. C., Devarakonda, S., Laznik, D., Choi, J. H., Ono, H., Olsen, J. V., & Spiegelman, B. M. (2011) · Genes & Development · doi:10.1101/gad.2054711 · Cited by 118
Pfefferkorn, J. A., Guzmán-Pérez, A., Litchfield, J., Aiello, R. J., Treadway, J. L., Pettersen, J. C., Minich, M. L., Filipski, K. J., Jones, C. S., Tu, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2014887 · Cited by 113
Burgess, S. C., Leone, T. C., Wende, A. R., Croce, M. A., Chen, Z., Sherry, A. D., Malloy, C. R., & Finck, B. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600050200 · Cited by 112
Glucose homeostasis, obesity and diabetes
Bano, G. (2013) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.02.007 · Cited by 112
Kaidanovich‐Beilin, O., & Eldar-Finkelman, H. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090266 · Cited by 111
Kelly, R. P., Garhyan, P., Raddad, E., Fu, H., Lim, C. N., Prince, M. J., Pinaire, J. A., Loh, M. T., & Deeg, M. A. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12446 · Cited by 110
A Novel Glucagon Receptor Antagonist Inhibits Glucagon-Mediated Biological Effects
Qureshi, S. A., Candelore, M. R., Xie, D., Yang, X., Tota, L. M., Ding, V. D. H., Li, Z., Bansal, A., Miller, C. O., Cohen, S. M., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3267 · Cited by 109
Befroy, D. E., Perry, R. J., Jain, N., Dufour, S., Cline, G. W., Trimmer, J. K., Brosnan, J. M., Rothman, D. L., Petersen, K. F., & Shulman, G. I. (2013) · Nature Medicine · doi:10.1038/nm.3415 · Cited by 99
Fine-Tuning Multiprotein Complexes Using Small Molecules
Thompson, A. D., Dugan, A. E., Gestwicki, J. E., & Mapp, A. K. (2012) · ACS Chemical Biology · doi:10.1021/cb300255p · Cited by 98
Song, X., Chen, J., Zhao, M., Zhang, C., Yu, Y., Lonard, D. M., Chow, D., Palzkill, T. G., Xu, J., O’Malley, B. W., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604274113 · Cited by 97
COP1 Functions as a FoxO1 Ubiquitin E3 Ligase to Regulate FoxO1-mediated Gene Expression
Kato, S., Ding, J., Pisck, E., Jhala, U. S., & Du, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801011200 · Cited by 96
Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors
Lloyd, D. J., Jean, D. J. S., Kurzeja, R. J. M., Wahl, R. C., Michelsen, K., Cupples, R. L., Chen, M., Wu, J. W. Y., Sivits, G. N., Helmering, J., et al. (2013) · Nature · doi:10.1038/nature12724 · Cited by 95
Fontaine, F. R., Overman, J. P., & François, M. (2015) · Cell Regeneration · doi:10.1186/s13619-015-0015-x · Cited by 90
van Poelje, P. D., Potter, S. C., Chandramouli, V. C., Landau, B. R., Dang, Q., & Erion, M. D. (2006) · Diabetes · doi:10.2337/db05-1443 · Cited by 87
Xiong, Y., Guo, J. W., Candelore, M. R., Liang, R., Miller, C., Dallas-Yang, Q., Jiang, G., McCann, P. E., Qureshi, S. A., Tong, X., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300579z · Cited by 87
Gómez-Valadés, A. G., Vidal‐Alabró, A., Molas, M., Boada, J., Bermúdez, J., Bartrons, R., & Perales, J. C. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.026 · Cited by 87
Glycogen Phosphorylase Inhibition in Type 2 Diabetes Therapy
Baker, D. J., Timmons, J. A., & Greenhaff, P. L. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2453 · Cited by 87
Ertiprotafib Improves Glycemic Control and Lowers Lipids via Multiple Mechanisms
Erbe, D. V., Wang, S., Zhang, Y., Harding, K., Kung, L., Tam, M., Stolz, L. E., Xing, Y., Furey, S., Qadri, A., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.005553 · Cited by 87
Oh, K., Park, J., Kim, S. S., Oh, H., Choi, C. S., & Koo, S. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002986 · Cited by 85
Matsuda, M., DeFronzo, R. A., Glass, L. C., Consoli, A., Giordano, M., Bressler, P., & DelPrato, S. (2002) · Metabolism · doi:10.1053/meta.2002.34700 · Cited by 85
Arany, Z. P., Wagner, B. K., Ma, Y., Chinsomboon, J., Laznik, D., & Spiegelman, B. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800979105 · Cited by 84
Cited by
Islam, M. T., Tuday, E., Allen, S., Kim, J., Trott, D. W., Holland, W. L., Donato, A. J., & Lesniewski, L. A. (2023) · Aging Cell · doi:10.1111/acel.13767 · Cited by 313
VerPlank, J. J. S., Lokireddy, S., Zhao, J., & Goldberg, A. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809254116 · Cited by 122
Momordica charantia: A popular health-promoting vegetable with multifunctionality
Wang, S., Li, Z., Yang, G., Ho, C.-T., & Li, S. (2017) · Food & Function · doi:10.1039/c6fo01812b · Cited by 104
Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis
De Groot, J., Wu, D., Flynn, D., Robertson, D., Grant, G., & Sun, J. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i2.170 · Cited by 77
SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control
Montgomery, M. K., Bayliss, J., Devereux, C., Bezawork-Geleta, A., Roberts, D., Huang, C., Schittenhelm, R. B., Ryan, A., Townley, S. L., Selth, L. A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz8048 · Cited by 63
Metadata
- Authors
- Rines, A. K., Sharabi, K., Tavares, C. D. J., & Puigserver, P.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2016-08-12
- Volume
- 15
- Issue
- 11
- Pages
- 786-804
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2509220708
- Cited by
- 375
- References
- 251
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.